"Phelps Health is one of Missouri's leading regional referral centers, serving over 200,000 residents in south-central Missouri. Phelps Health is county-owned, non-tax supported and is overseen by a five-member elected board. Phelps Health employs more than 1,800 people, including 100-plus providers. Phelps Health, which includes a hospital licensed for 242 patient beds, serves a six-county area, with its main campus and several clinics located in Rolla, Missouri. Phelps Health also has clinics in Salem, St. James, Vienna and Waynesville, Missouri."

During the past decade, Bond Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bond Clinic" #1 sponsor was "CTI BioPharma" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Cephalon" with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "Threshold Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bond Clinic" #1 collaborator was "PPD" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bond Clinic" are "Cancer" (1 trials), "Colorectal Carcinoma" (1 trials), "Lung Cancer" (1 trials), "Lymphoma" (1 trials) and "NSCLC" (1 trials). Many other conditions were trialed in "Bond Clinic" in a lesser frequency.

Most popular intervention types in "Bond Clinic" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (2 trials), "paclitaxel poliglumex" (2 trials), "Glufosfamide" (1 trials), "OraVescent fentanyl citrate" (1 trials) and "VELCADE TM (bortezomib) for Injection, or PS-341" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bond Clinic" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bond Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Bond Clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bond Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".